From Discovery to Approval: Mapping the Global Health R&D Pipeline
An end-to-end interactive view of global health R&D pipeline, from investigational candidates to approved products reaching people in need.
Scale of R&D by global health area
Toggle views: Candidates in development | Approved products
This bubble chart shows the relative scale of product development landscape across global health areas. Each bubble represents a global health area, with its size indicating the number of products in scope. Use the dropwdown menu to switch between candidates in development and approved products to compare where R&D activity and market-ready solutions are most concentrated.
Geographic Distribution of Clinical Trials and Developers
A global snapshot of R&D activity, highlighting where clinical trials are conducted and where product developers are based.
The global heat map illustrating where R&D activity is concentrated across countries. Use the tabs to switch between the location of clinical trials and the location of developers. Darker shades indicate countries with a higher concentration of trials or developers, highlighting global research hubs as well as regions with limited R&D presence.
Portfolio overview by global health area
Explore Portfolio AnalysisA cross-section of the R&D pipeline by global health area and development stage. Each horizontal bar represents a global health area, with colour-coded segments showing the number of candidates and approved products. Use the filters above to focus on specific product types or R&D stage, and click items in the legend to turn individual stages on or off to compare how pipelines are distributed across the development lifecycle.
Cross pipeline analytics
Make custom comparisonA high-level view of how the global R&D pipeline evolves over time across development stages. this chart shows changes in the number of candidates in early development, late development and approved products across IGH its review years. Use the filters to focus on a specific global health area or product type. Click on the legend to turn individual development stages on or off to compare how the pipelines are progrssing through the R&D lifecycle over time.
Reports and Insights
Discover the insights that two decades of global health data have given us.
The ripple effect: how global health R&D delivers for everyone
This report shows how investments in global health R&D deliver significant health and economic progress for HI...
Read moreState of disunion: The impact of US funding cuts on global health R&D
This report offers a quantified assessment of the actual and potential impact of the 2025 US funding cuts giving a system-wide, data-driven picture of the ripple effects by...
Read moreFrom malaria research to protecting aging populations: AS01 Adjuvant in Shingrix
This case study focuses on the benefits of AS01 adjuvant, initially advanced through malaria research...
Read more